Home Other Building Blocks 5511-18-2
5511-18-2,MFCD00042109
Catalog No.:AA003DU4

5511-18-2 | 1-Adamantanecarboxamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
97%
in stock  
$29.00   $21.00
- +
1g
>97.0%(GC)
in stock  
$32.00   $23.00
- +
10g
97%
in stock  
$253.00   $178.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA003DU4
Chemical Name:
1-Adamantanecarboxamide
CAS Number:
5511-18-2
Molecular Formula:
C11H17NO
Molecular Weight:
179.2588
MDL Number:
MFCD00042109
SMILES:
NC(=O)C12CC3CC(C2)CC(C1)C3
Properties
Properties
 
BP:
343.3°C at 760 mmHg  
Form:
Solid  
MP:
188-190 °C(lit.)  
Refractive Index:
1.5065 (estimate)  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
218  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
2  

Literature

Title: Adamantyl carboxamides and acetamides as potent human 11β-hydroxysteroid dehydrogenase type 1 inhibitors.

Journal: Bioorganic & medicinal chemistry 20121101

Title: Structure-based and property-compliant library design of 11β-HSD1 adamantyl amide inhibitors.

Journal: Methods in molecular biology (Clifton, N.J.) 20110101

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Α-galactosylceramide analogs with weak agonist activity for human iNKT cells define new candidate anti-inflammatory agents.

Journal: PloS one 20100101

Title: Selective P2X(7) receptor antagonists for chronic inflammation and pain.

Journal: Purinergic signalling 20090301

Title: Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20070515

Title: Synthesis and biological evaluation of heterocycle containing adamantane 11beta-HSD1 inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20061015

Title: New lamellar structure formed by an adamantyl derivative of cholic acid.

Journal: The journal of physical chemistry. B 20060720

Title: P2X(7) receptor: Death or life?

Journal: Purinergic signalling 20050901

Title: Structure-activity relationship studies of a series of antiviral and antibacterial aglycon derivatives of the glycopeptide antibiotics vancomycin, eremomycin, and dechloroeremomycin.

Journal: Journal of medicinal chemistry 20050602

Title: Adamantylsulfanyl- and N-adamantylcarboxamido-derivatives of heterocycles and phenols: synthesis, crystal structure, tumor necrosis factor-alpha production-enhancing properties, and theoretical considerations.

Journal: Chemistry & biodiversity 20041001

Title: Crystal structures of dipeptides containing the Dmt-Tic pharmacophore.

Journal: Journal of medicinal chemistry 20021205

Title: Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.

Journal: Journal of medicinal chemistry 20020117

Title: Synthesis and modulation of cytokine production by two new adamantane substituted acyclic desmuramyldipeptide analogs.

Journal: Die Pharmazie 20010701

Title: Inhibition of human multidrug resistance P-glycoprotein 1 by analogues of a potent delta-opioid antagonist.

Journal: Brain research 20010525

Title: Capture of a single molecule in a nanocavity.

Journal: Science (New York, N.Y.) 20010126

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:5511-18-2 Molecular Formula|5511-18-2 MDL|5511-18-2 SMILES|5511-18-2 1-Adamantanecarboxamide